These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 21956414)

  • 1. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations.
    Ngeow J; Mester J; Rybicki LA; Ni Y; Milas M; Eng C
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E2063-71. PubMed ID: 21956414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline PTEN, SDHB-D, and KLLN alterations in endometrial cancer patients with Cowden and Cowden-like syndromes: an international, multicenter, prospective study.
    Mahdi H; Mester JL; Nizialek EA; Ngeow J; Michener C; Eng C
    Cancer; 2015 Mar; 121(5):688-96. PubMed ID: 25376524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KLLN epigenotype-phenotype associations in Cowden syndrome.
    Nizialek EA; Mester JL; Dhiman VK; Smiraglia DJ; Eng C
    Eur J Hum Genet; 2015 Nov; 23(11):1538-43. PubMed ID: 25669429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53.
    Ni Y; He X; Chen J; Moline J; Mester J; Orloff MS; Ringel MD; Eng C
    Hum Mol Genet; 2012 Jan; 21(2):300-10. PubMed ID: 21979946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline alterations in RASAL1 in Cowden syndrome patients presenting with follicular thyroid cancer and in individuals with apparently sporadic epithelial thyroid cancer.
    Ngeow J; Ni Y; Tohme R; Song Chen F; Bebek G; Eng C
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1316-21. PubMed ID: 24712574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes.
    Ni Y; Zbuk KM; Sadler T; Patocs A; Lobo G; Edelman E; Platzer P; Orloff MS; Waite KA; Eng C
    Am J Hum Genet; 2008 Aug; 83(2):261-8. PubMed ID: 18678321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cowden syndrome-associated germline succinate dehydrogenase complex subunit D (SDHD) variants cause PTEN-mediated down-regulation of autophagy in thyroid cancer cells.
    Yu W; Ni Y; Saji M; Ringel MD; Jaini R; Eng C
    Hum Mol Genet; 2017 Apr; 26(7):1365-1375. PubMed ID: 28164237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of PTEN protein dosage in predicting for underlying germline PTEN mutations among patients presenting with thyroid cancer and Cowden-like phenotypes.
    Ngeow J; He X; Mester JL; Lei J; Romigh T; Orloff MS; Milas M; Eng C
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2320-7. PubMed ID: 23066114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cowden syndrome-associated germline SDHD variants alter PTEN nuclear translocation through SRC-induced PTEN oxidation.
    Yu W; He X; Ni Y; Ngeow J; Eng C
    Hum Mol Genet; 2015 Jan; 24(1):142-53. PubMed ID: 25149476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
    Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
    PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome.
    Bennett KL; Mester J; Eng C
    JAMA; 2010 Dec; 304(24):2724-31. PubMed ID: 21177507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer.
    Ni Y; Seballos S; Ganapathi S; Gurin D; Fletcher B; Ngeow J; Nagy R; Kloos RT; Ringel MD; LaFramboise T; Eng C
    Endocr Relat Cancer; 2015 Apr; 22(2):121-30. PubMed ID: 25694510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
    Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C
    Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers.
    Heald B; Mester J; Rybicki L; Orloff MS; Burke CA; Eng C
    Gastroenterology; 2010 Dec; 139(6):1927-33. PubMed ID: 20600018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Alterations in Tricarboxylic Acid Cycle Metabolites Associate with Cancer and Autism Phenotypes in Cowden Syndrome and Bannayan-Riley-Ruvalcaba Syndrome.
    Yehia L; Ni Y; Feng F; Seyfi M; Sadler T; Frazier TW; Eng C
    Am J Hum Genet; 2019 Oct; 105(4):813-821. PubMed ID: 31564436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.
    Ngeow J; Stanuch K; Mester JL; Barnholtz-Sloan JS; Eng C
    J Clin Oncol; 2014 Jun; 32(17):1818-24. PubMed ID: 24778394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifetime cancer risks in individuals with germline PTEN mutations.
    Tan MH; Mester JL; Ngeow J; Rybicki LA; Orloff MS; Eng C
    Clin Cancer Res; 2012 Jan; 18(2):400-7. PubMed ID: 22252256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E protects against lipid peroxidation and rescues tumorigenic phenotypes in cowden/cowden-like patient-derived lymphoblast cells with germline SDHx variants.
    Ni Y; Eng C
    Clin Cancer Res; 2012 Sep; 18(18):4954-61. PubMed ID: 22829200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest.
    Nizialek EA; Peterson C; Mester JL; Downes-Kelly E; Eng C
    Hum Mol Genet; 2013 Jun; 22(12):2451-61. PubMed ID: 23446638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers?
    Razavi SA; Modarressi MH; Yaghmaei P; Tavangar SM; Hedayati M
    Endocrine; 2017 Sep; 57(3):428-435. PubMed ID: 28755140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.